SOURCE: HealthSonix Inc.

February 20, 2007 13:00 ET

HealthSonix Invited to Present at Small Cap Expo in New York City

IRVINE, CA -- (MARKET WIRE) -- February 20, 2007 -- HealthSonix Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) announced today that it has been invited to the 2007 Small Cap Stock Expo in New York on February 28, 2007. HealthSonix is one of only 20 emerging companies invited to present at the event, which attracts small cap experts, analysts, and members of the investment community.

The expo will feature prestigious financial professionals including guest keynote speaker Mark Robins, Head of Research for Crown Point Group. Mr. Robins is a nationally recognized small-cap stock analyst and strategist as well as a regular contributor to Forbes Magazine.

The 2007 Small Cap Stock Expo includes a formal presentation to attendees, an exhibit space for one-on-one focus and demonstration, and an exclusive interview with MoneyTV, an interactive news source for small-cap companies broadcast on cable television, the Internet at, and through downloadable podcasts.

"This event provides HealthSonix the opportunity to present the company to potential investors, financial analysts and financial experts within the small cap market," says Dieter Doederlein, Vice President of Business Development. "As we continue to focus on AquaSonix Therapy expansion plans and introduction of enSonix@home, the personal home therapy device, we are extremely excited with the opportunity to present our recent achievements and company growth at this unique event."

HealthSonix Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects.

More information regarding HealthSonix and its products and services can be found on the World Wide Web at: or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information